Cargando…
VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways
The ability to control vascular endothelial growth factor (VEGF) signaling offers promising therapeutic potential for vascular diseases and cancer. Despite this promise, VEGF-targeted therapies are not clinically effective for many pathologies, such as breast cancer. VEGFR1 has recently emerged as a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736688/ https://www.ncbi.nlm.nih.gov/pubmed/29263797 http://dx.doi.org/10.1038/s41540-017-0037-9 |